DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/e6098b/future_therapeutic) has announced the addition of the "Future Therapeutic Drug Monitoring Market: US, Europe, Japan " report to their offering.
During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
"Therapeutic Dry Monitoring: US, Europe, Japan" is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five- and ten-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 306 pages and 69 tables.
For more information visit http://www.researchandmarkets.com/research/e6098b/future_therapeutic